BACKGROUND: Participation in clinical trials is critical for the success of evidence-based healthcare. Much previous research suggests that people take part in clinical trials mostly for altruistic reasons, and that deriving personal benefit is a secondary consideration. PURPOSE: To investigate patients' reasons for deciding whether to take part in clinical trials and the extent to which personal benefit may be a motivating factor. METHODS: A qualitative study utilizing in-depth semi-structured interviews. Participants were 42 men and women who had been asked to participate in clinical trials testing a range of interventions in different conditions, including some who did not participate or withdrew. Trials were based in either primary or s...
BACKGROUND AND AIMS: This study was conducted to investigate the views of patients and healthy volun...
The overall aim of this thesis was to study participants' understanding of clinical cancer trials, a...
BACKGROUND: Communication with patients contemplating Phase 1 cancer trial participation can be chal...
BACKGROUND: Participation in clinical trials is critical for the success of evidence-based healthcar...
Background: Participation in clinical trials is critical for the success of evidence-based healthcar...
Background Randomised controlled trials of healthcare interventions depend on the participation of v...
OBJECTIVE: To investigate people's experiences of and attitudes to participation in clinical trials....
Study goal: This study was carried out to answer the following research question: which motivation d...
Objectives: If patients are to reap the benefits of continued drug development, an understanding of ...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
Individuals participate in clinical research for a variety of reasons, dependant not only on the tri...
Successful advances in the treatment of advanced malignant diseases rely on recruitment of patients ...
Participation in randomised clinical trials (RCTs) entails taking part in the discovery of effects o...
INTRODUCTION: Clinical research is essential for the advancement of Medicine, especially regarding ...
BACKGROUND AND AIMS: This study was conducted to investigate the views of patients and healthy volun...
The overall aim of this thesis was to study participants' understanding of clinical cancer trials, a...
BACKGROUND: Communication with patients contemplating Phase 1 cancer trial participation can be chal...
BACKGROUND: Participation in clinical trials is critical for the success of evidence-based healthcar...
Background: Participation in clinical trials is critical for the success of evidence-based healthcar...
Background Randomised controlled trials of healthcare interventions depend on the participation of v...
OBJECTIVE: To investigate people's experiences of and attitudes to participation in clinical trials....
Study goal: This study was carried out to answer the following research question: which motivation d...
Objectives: If patients are to reap the benefits of continued drug development, an understanding of ...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
Individuals participate in clinical research for a variety of reasons, dependant not only on the tri...
Successful advances in the treatment of advanced malignant diseases rely on recruitment of patients ...
Participation in randomised clinical trials (RCTs) entails taking part in the discovery of effects o...
INTRODUCTION: Clinical research is essential for the advancement of Medicine, especially regarding ...
BACKGROUND AND AIMS: This study was conducted to investigate the views of patients and healthy volun...
The overall aim of this thesis was to study participants' understanding of clinical cancer trials, a...
BACKGROUND: Communication with patients contemplating Phase 1 cancer trial participation can be chal...